Turkey Braces For More Drug Access Problems As New Fixed Euro Rate Nears
Executive Summary
With the Turkish medicine shortage situation as bad as ever, the national pharmacists’ association has said that 521 products are now “hard to find,” while 141 are unavailable. A government move to adjust the fixed euro rate on which drug prices are calculated is not expected to do much to solve the problem.
You may also be interested in...
Turkey’s New Fixed Euro Rate Spells More Pressure For Industry
The Turkish government has set the fixed Euro rate to calculate drug prices at TRY3.40 for 2019.
Medtech Procurement A Victim Of Turkey’s Ongoing Economic Troubles
The devaluation of the Turkish Lira since May is making imports of medical devices more expensive and putting hospital procurement under renewed pressure. The local medtech industry associations TUMDEF and ARTED describe the problems ̶ and the solutions ̶ to Medtech Insight.
A Bright Moment At Last In Turkish Medtech Debt Payments Saga
Turkish medtechs’ demands for payment of their outstanding hospital debts went unheeded in 2021, but the government has finally started a payment process. It is not evenly applied, and has started in a small way, but the industry feels encouraged on more than one count.